Ensysce Biosciences Stock Doubles In One Trading Session – Here’s Why | Official Website of Louis Velazquez, entrepreneur, finance guy and tech innovator

All NewsApril 23, 2025

Ensysce Biosciences Stock Doubles In One Trading Session – Here’s Why

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent